Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06339203 · ClinicalTrials.gov registry record · NA
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
A NA study of Cesarean Section Complications and Cesarean Section; Infection, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06339203: Recruiting NA study of Cesarean Section Complications and Cesarean Section; Infection, sponsored by Loma Linda University.
NCT06339203 is a NA study of Cesarean Section Complications and Cesarean Section; Infection that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 400 participants, below the 729-participant average among 9 other Cesarean Section Complications trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06339203, a NA study of Cesarean Section Complications and Cesarean Section; Infection, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.
Primary Outcome
Wound Evaluation scale will be used to evaluate appropriate healing in the following categories: redness, bruising, discharge, tissue breakdown, wound infection
Conditions Studied
Interventions
- DRUG Normal Saline
- DEVICE Irrisept
Study Locations (1)
California
- Loma Linda University - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06339203 shows while recruiting
NCT06339203 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 729-participant average among 9 other Cesarean Section Complications trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with Cesarean Section Complications appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.
NCT06339203 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06339203 about?
NCT06339203 is a clinical study titled "Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)". This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile wate...
What is the current status of trial NCT06339203?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-06-05. Estimated completion is 2026-12.
What conditions does trial NCT06339203 study?
This clinical trial studies the following conditions: Cesarean Section Complications, Cesarean Section; Infection.
What interventions are being tested in trial NCT06339203?
The interventions under investigation include: Normal Saline (DRUG), Irrisept (DEVICE).
Who is sponsoring clinical trial NCT06339203?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06339203 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06339203's enrollment target sits among peer trials
400 3rd of 9 higher than 7 of 9 other Cesarean Section Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Section Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Durometer for Measuring Uterine Tone
RECRUITING · NA
-
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
RECRUITING · NA
-
An Evaluation of the Team Birth Project
COMPLETED · NA
-
Oxytocin Pharmacokinetics and Pharmacodynamics
RECRUITING · Phase 2
-
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
COMPLETED · Phase 3
-
Arm and Ankle Blood Pressure Cuffs During C-Section
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI